Biotech Startups

Circulate Health provides therapeutic plasma exchange (TPE) treatments for longevity care, offering science-based clinical interventions to extend healthspan. The company enables clinics to deliver TPE services to patients and conducts research to advance the clinical evidence base for longevity medicine.

2 investors

2 investors

The EVERY Company produces animal-free egg proteins for food companies using a patented fermentation process. Its ingredients are designed to match the functionality of conventional egg proteins while being produced without animals.

2 investors

Clariness provides clinical trial patient recruitment, enrollment feasibility, and engagement services for pharmaceutical and biotech sponsors running studies. Following its merger with SubjectWell, it operates an integrated enrollment ecosystem spanning 400+ indications and 60+ countries.

2 investors

Clear Genetics builds HIPAA-compliant software that automates the delivery of genetic services and integrates genetics into routine patient care. It serves health systems, clinics, and commercial labs across the United States.

2 investors

Ipsen is a biopharmaceutical group that publishes financial, legal, and non-financial reporting for shareholders, investors, and the public through documents such as its Universal Registration Document. The page is the investor reports and accounts section of the company's corporate site.

2 investors

Commercial-stage diagnostics company developing affordable cancer diagnostics tests.

2 investors

Cleveland HeartLab provides diagnostic blood tests that use a multimarker approach, including inflammatory biomarkers such as hsCRP and MPO, to assess and stratify an individual's cardiovascular disease risk. Its tests are offered to healthcare providers to improve cardiovascular risk assessment beyond traditional measures like LDL-C.

2 investors

ClostraBio develops next-generation probiotics and a platform for delivering bacterial metabolites to support gut health, targeting inflammatory bowel disease (IBD) and food allergy. Its lead product, CLB101 (Anaerostipes caccae), is a probiotic aimed at supporting gut barrier function, immunity, and microbiome balance, offered both as a dietary supplement and a therapeutic delivery platform.

2 investors

Calira provides scheduling and management software for scientific lab equipment, letting LabOps teams book shared instruments, track maintenance, monitor utilisation, and build a searchable equipment directory across one or multiple labs and sites. It also exports usage data for integration with ELN, AI, or BI platforms.

2 investors

CND Life Sciences develops skin-based neurodiagnostic tests, including a test to detect abnormal alpha-synuclein in skin biopsies to help physicians diagnose Parkinson's disease and related synucleinopathies. It operates a CLIA-certified and CAP-accredited pathology lab serving clinicians and patients.

2 investors

Coagulant Therapeutics is a biopharmaceutical company, formed in 2019, developing biologics with a focus on hematology and coagulation-related therapeutics.

2 investors

CoBX Bio is a drug discovery company working in chemical proteomics. The available page content is limited to legal notices and a tagline, offering little detail about specific programs or products.

2 investors

2 investors

Codagenix develops viral vaccines and virotherapeutics using codon deoptimization, a method for engineering attenuated viruses. The company applies this platform in clinical development, drawing on expertise in virology, computational science, and patient care.

2 investors

Codebreaker edits genetic variants into primary human cells and measures their functional effects, generating causal data to train AI models in genomics. It targets researchers and platforms needing functionally resolved variant data as ground truth.

2 investors

Cambridge, MA clinical-stage biotech developing engineered exosome therapeutics; IPO'd on NASDAQ in 2020, later restructured.

2 investors

Coegin Pharma develops and commercializes advanced cosmetic peptide technologies for hair and skin care, targeting the global longevity and wellness market. The company's flagship product, Follicopeptide®, addresses hair thinning, while a second innovation, NPP-4, targets skin tone enhancement.

2 investors

Cognito Therapeutics develops Spectris, a non-invasive sensory stimulation technology platform to treat neurodegenerative diseases including Alzheimer's by improving cognitive performance. The company serves patients with neurodegenerative conditions and aims to transform disease management through clinical-to-commercial pathways in the neurological therapeutics sector.

2 investors

Cognoptix develops the Sapphire II system, a non-invasive laser eye scanning device paired with an eye ointment that binds to beta amyloid proteins in the lens of the eye to aid early detection and diagnosis of Alzheimer's disease. The company builds diagnostic devices and agents for clinical, commercial, and academic research use and works with pharma partners and academic institutes.

2 investors

Cogstate provides digital cognitive assessments, electronic clinical outcome assessment (eCOA) support, and endpoint data quality services for biopharmaceutical companies, academic institutions, and clinicians. Founded in 1999, it also supplies cognitive testing tools used in sports medicine and clinical trials for neurological and psychiatric conditions.

2 investors

CollimateHealth develops a clinically scalable microbeam radiation technology for cancer treatment, delivering arrays of narrow, micrometer-scale radiation beams at higher doses than conventional broad-beam radiation oncology. The technology aims to trigger immune responses against cancer cells and improve delivery of chemotherapy and immunotherapy into tumor tissue.

2 investors

Color operates a nationwide, oncologist-led Virtual Cancer Clinic that delivers cancer screening, early detection, diagnosis, treatment management, and survivorship care at population scale. It serves employers, unions, health plans, and public sector organizations across the United States, combining clinical genetics and lab testing with technology to improve cancer outcomes and lower costs.

2 investors

Colospan develops the CG-100, an internal bypass medical device for colorectal surgery that provides an alternative to stoma pouches. The company serves surgeons and patients requiring colorectal procedures in the medtech sector.

2 investors